Clinical Trials
New selective estrogen receptor modulator for menopausal symptoms reported
Published in Women's Health Weekly, March 30th, 2006
Now in a phase 2 clinical trial of MF101, Bionovo has begun recruiting participants to evaluate them for the treatment of menopausal symptoms. MF101 is a selective estrogen receptor modulator, unlike other available hormone therapies.
This second clinical trial of MF101 followed the initial trial conducted at the University of California, San Francisco under the auspices of Deborah...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Angina
Angina investigations and therapy are affected by gender bias - Breast Cancer
Potential link between aluminium salts in deodorants and breast cancer warrants further research - Cardiovascular Disease
Cardiovascular disease risk was not affected by reduced-fat diet - Environmental Health
Public health effects of exposure to toxic metals reported in new study - Obstetrics
Estrogen-free birth control pill may be choice for child-bearing-age women - Adenocarcinomas
Fibroblast growth factor has oncogenic activity in ovarian endometrioid adenocarcinomas - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
